Stock Alert: Ekso Bionics Up 8%

By RTTNews Staff Writer ✉ | Published: 1/11/2021 10:33 AM ET

Shares of Ekso Bionics Holdings Inc. (EKSO) are gaining over 8% on Monday morning despite no-stock related news.

EKSO is currently trading at $7.49, up $0.57 or 8.23%, on the Nasdaq.

Ekso Bionics designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the US and internationally.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Editors Pick

Boeing, NASA Further Delay Starliner Crew Flight Launch

Boeing and NASA announced further delay in the much expected launch of Starliner Crew Flight to the International Space Station following certain emerging issues with the capsule. Boeing has been developing its Starliner spacecraft after winning nearly $5 billion in contracts under NASA's Commercial Crew Program. Starliner's first crewed flight was earlier prepared for an April launch.

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

Naperville, Illinois-based Chervon North America Inc. is recalling EGO Power+ Cordless Brushless Hedge Trimmers citing laceration hazard, the U.S. Consumer Product Safety Commission said. The recall involves EGO Power+ Model HT2410 Cordless Brushless Hedge Trimmers that were manufactured prior to March 30, 2019. About 85,000 units were sold in the United States and about 4,000 units were sold...

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Paterson, New Jersey - based E.N.A. Meat Packing Inc. is recalling around 39,947 pounds of frozen, raw lamb products that were imported without the benefit of import reinspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The products subject to recall include cartons weighing around 40-lb., containing raw frozen pieces of "Simunovic S.A. Frozen Bon

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

COVID-19: Drugs in Development

Follow RTT

Most Read
Most Emailed

Stock Alert: Ekso Bionics Up 8%

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

Constellation To Acquire NRG's 44% Stake In South Texas Project Electric Generating Station

Seagen To Be Acquired By Pfizer For $43 Bln

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

U-Haul Holding Shares Down On Lower Earnings In Q4

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

AstraZeneca's Lynparza Gets FDA Approval For BRCAm Prostate Cancer

Magnachip To Spin-off Display And Power Businesses Into Separate Entities

Dollar General Down In Pre-market On Q1 Results, Outlook

Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

VEEVA SYSTEMS INC Q1 Profit Increases, beats estimates

Constellation To Acquire NRG's 44% Stake In South Texas Project Electric Generating Station

MEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEO

Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

Former Wells Fargo Executive Tolstedt Agrees To Settle SEC Fraud Charges

Hormel Foods Reaffirms FY23 Outlook - Update

8x8 Names Samuel Wilson CEO

Svenska Handelsbanken To Sell Certain Operations In Finland

Hewlett Packard Enterprise Q2 Profit Increases, beats estimates

CAE Q4 Earnings Spike

Guy Carpenter To Buy Israeli Insurance Broker Re Solutions For Undisclosed Sum

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

WH Smith 13-week Group Revenue Rises; Says Full-year Expectations Modestly Improved